These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 4844515)

  • 21. Administration of prostaglandins by various routes for induction of abortion. Merits and demerits.
    Krishna U; Ganguli AC; Mandlekar AV; Purandare VN
    Prostaglandins; 1978 Apr; 15(4):685-93. PubMed ID: 674699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Editorial: Prostaglandins and the uterus.
    Lancet; 1973 Oct; 2(7833):829-30. PubMed ID: 4126622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostaglandin E2 vaginal suppository as a midtrimester abortifacient.
    Bolognese RJ; Corson SL
    Am J Obstet Gynecol; 1974 Sep; 120(2):281-4. PubMed ID: 4415348
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of intra-amniotic (15S)-15-methyl-PGF2 alpha and intravaginal prostaglandin E2 for second-trimester uterine evacuation.
    Perry KG; Roberts WE; Martin RW; Magann EF; Sullivan DL; Morrison JC
    J Perinatol; 1998; 18(1):24-7. PubMed ID: 9527940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Letter: intrauterine prostaglandins for outpatient termination of very early pregnancy.
    Karim SM
    Lancet; 1973 Oct; 2(7832):794. PubMed ID: 4126492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of prostaglandins in obstetrics.
    Karim SM; Trussell RR
    East Afr Med J; 1971 Jan; 48(1):1-12. PubMed ID: 5572726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of prostaglandin F2a on the contractility of the pregnant human uterus].
    Romero-Salinas G; Ramírez-Jiménez D; García-Peña J; Ruiz-Velasco V; Bravo-Sandoval J
    Ginecol Obstet Mex; 1974 Jun; 35(212):627-56. PubMed ID: 4419223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of prostaglandin E1 on the midpregnant human uterus. Intravenous, intramuscular, intra-amniotic, and vaginal administration.
    Wiqvist N; Bygdeman M; Kwon SU; Mukherjee T; Roth-Brandel U
    Am J Obstet Gynecol; 1968 Oct; 102(3):327-32. PubMed ID: 5675883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prostaglandin abortions in an outpatient ward].
    Ylikorkala O; Jouppila P; Ylöstalo P; Järvinen PA
    Duodecim; 1974; 90(19):1308-16. PubMed ID: 4426280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative study of two types of prostaglandins for abortion during the second trimester.
    Rettenmaier MA; Hanson FW
    Surg Gynecol Obstet; 1983 May; 156(5):585-8. PubMed ID: 6573807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostaglandins and therapeutic abortion: summary of present status.
    Hendricks CH
    J Reprod Med; 1972 Dec; 9(6):466-8. PubMed ID: 4648931
    [No Abstract]   [Full Text] [Related]  

  • 32. Midtrimester abortion by prostaglandin impact.
    Saldana LR; Schulman H; Yang WH; Cunningham MA; Randolph G
    Obstet Gynecol; 1974 Oct; 44(4):579-85. PubMed ID: 4414679
    [No Abstract]   [Full Text] [Related]  

  • 33. Prostaglandins: overview in obstetrics and gynecology.
    Singh EJ; Zuspan FP
    J Reprod Med; 1974 May; 12(5):211-4. PubMed ID: 4599109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of prostaglandin E2 vaginal suppositories in intrauterine fetal death and missed abortion.
    Bailey CD; Newman C; Ellinas SP; Anderson GG
    Obstet Gynecol; 1975 Jan; 45(1):110-3. PubMed ID: 1110809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of two prostaglandins used to terminate midtrimester pregnancy.
    Gookin KS; White CK; Whitworth NS; Wiser WL; Morrison JC
    South Med J; 1984 Jun; 77(6):717-8, 721. PubMed ID: 6587588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interrelationship between oxytocin (endogenous and exogenous) and prostaglandins.
    Gillespie A
    Adv Biosci; 1973; 9():761-6. PubMed ID: 4805888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early midtrimester pregnancy termination. A comparison of dilatation and evacuation and intravaginal prostaglandin E2.
    Robins J; Surrago EJ
    J Reprod Med; 1982 Jul; 27(7):415-9. PubMed ID: 6956734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prostaglandins in the control of fertility? Critical review].
    Carol W; Klinger G
    Z Arztl Fortbild (Jena); 1974 Aug; 68(16):846-8. PubMed ID: 4613030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pregnancy termination in midtrimester --reviews of major methods--.
    Chaudry SL; Hunt WB; Wortman J
    Popul Rep F; 1976 Sep; (5):65-83. PubMed ID: 791731
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison between intraamniotic PGF2 alpha and vaginal PGE2 for second-trimester abortion.
    Lebed JP; Rubin A; Millman AE
    Obstet Gynecol; 1980 Jul; 56(1):90-6. PubMed ID: 7383493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.